Transforming the Treatment of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM), the most common inherited cardiac disorder, is defined by the presence of increased left ventricular (LV) wall thickness that is not caused by secondary factors. Despite this high prevalence, the majority of individuals with HCM are undiagnosed and untreated. HCM is a disease of the sarcomeres, which are responsible for contraction within cardiac myocytes. Physicians must be able to understand the role of sarcomere dysfunction in the development of HCM and how cardiac myosin inhibitors disrupt these pathological processes.
Supported by an independent educational grant from Cytokinetics.

[@bearclaw5115]

Intelligent people sharing evidence based information in an open minded way, to help other people with a problem that they themselves don't have. This is humanity at it's very best!
Thank you for the talk, I understand my treatment options much better now.

[@CrisCole2022]

My son was born with this condition. Had a cardiac arrest 3 years ago. I chocked him twice with the AED. Went to hospital and had a pacemaker implanted. He takes sotalol twice a day and had 2 episodes after the surgery. Today he is 16 years old ❤

[@pennygirl99]

God bless him, I was diagnosed with this a few days ago and I have been so scared and depressed. I have been trying to read and find as much info as I can.